This is a landmark day for peptides! I recorded this at 6 AM the morning between day one and day two of the FDA's Pharmacy Compounding Advisory Committee (PCAC) meeting, and I'm breaking down exactly what happened, why it matters, and what it means for you depending on where you live.
On day one, the committee voted YES on all four peptides they reviewed: BPC-157, TB-500, KPV, and MOTS-c. This went against the FDA scientists' own recommendation. There was an audible gasp in the room. Today they're voting on DSIP, Epitalon, and Semax, and I expect all three to pass too.
If you'd like to work with me one-on-one, you can book a free call here.
Timestamps:
00:00 Welcome + why this is a landmark peptide moment
04:50 What the FDA PCAC panel voted on and why it shocked everyone
08:00 Peptides have a champion at the very top (RFK Jr.) + the $2.2B opportunity
10:00 Why this is a win. Safety through legitimacy, licensed compounding pharmacies, real quality standards
13:50 Why national validation matters, and what this means if you're already using peptides
17:30 BPC-157. The recovery superstar. Doses, cycles, uses
20:35 TB-500. The recovery partner. The Wolverine stack with BPC-157
22:00 KPV. The anti-inflammatory gem for gut and skin
23:10 MOTS-c. Exercise mimetic, metabolic and mitochondrial support
25:35 What's on the vote today. DSIP for sleep, Epitalon for longevity, Semax for focus
27:30 Free base vs acetate. What you need to know
28:35 What this means for women. Why our physiology needs its own research
30:55 The future. Nothing is fully legal yet. The FDA still gets the final vote
33:35 The gray market will shrink but not dissolve
34:30 If you don't have a doctor. How the US telehealth model will work
35:20 What this means for Canadians and global listeners
37:00 Peptides are here to stay. The cultural moment already happened
38:15 Work with me one-on-one + my vetted peptide sources
Podden och tillhörande omslagsbild på den här sidan tillhör
Brittany Ford. Innehållet i podden är skapat av Brittany Ford och inte av,
eller tillsammans med, Poddtoppen.